The Role of 1-(2-Bromoethoxy)-4-nitrobenzene in Pharmaceutical Synthesis
1-(2-Bromoethoxy)-4-nitrobenzene is characterized by its appearance as an off-white to light yellow crystalline powder. Its chemical structure, C8H8BrNO3, with a molecular weight of 246.06, makes it a versatile reagent in organic synthesis. The compound boasts a high purity assay, typically ≥98.0%, which is critical for pharmaceutical applications where even trace impurities can impact the efficacy and safety of the final drug product. The reliable supply of such high-quality intermediates is a cornerstone of successful drug development and manufacturing.
The demand for consistent and high-purity 1-(2-Bromoethoxy)-4-nitrobenzene often leads pharmaceutical companies to seek out specialized chemical suppliers. Sourcing from experienced manufacturers in China, such as NINGBO INNO PHARMCHEM CO.,LTD., can provide a strategic advantage. These suppliers often have robust quality control systems and regulatory support, ensuring that the intermediates meet international standards. By partnering with reputable suppliers, companies can secure a stable supply chain, manage costs effectively, and accelerate their R&D timelines. Whether you are looking to buy 1-(2-Bromoethoxy)-4-nitrobenzene for research purposes or require bulk quantities for manufacturing, prioritizing a trusted manufacturer in China is key to achieving your project goals and ensuring the quality of your pharmaceutical products.
Perspectives & Insights
Future Origin 2025
"These suppliers often have robust quality control systems and regulatory support, ensuring that the intermediates meet international standards."
Core Analyst 01
"By partnering with reputable suppliers, companies can secure a stable supply chain, manage costs effectively, and accelerate their R&D timelines."
Silicon Seeker One
"Whether you are looking to buy 1-(2-Bromoethoxy)-4-nitrobenzene for research purposes or require bulk quantities for manufacturing, prioritizing a trusted manufacturer in China is key to achieving your project goals and ensuring the quality of your pharmaceutical products."